Molecular analysis of prognostically significant markers of chronic lymphocytic leukemia
Mgr. Erika Tomková, RNDr. Miroslav Tomka, PhD., RNDr. Renáta Lukačková, Mgr. Jakub Petrík
Chronic lymphocytic leukemia (CLL) is a clinically and biologically substantially heterogenous disease. In general, patients are classified into two groups: patients with indolent disease form...